期刊
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
卷 46, 期 1, 页码 27-42出版社
WALTER DE GRUYTER GMBH
DOI: 10.1515/CCLM.2008.006
关键词
blood plasma and serum; coronary heart disease; data analysis; diagnostics; lipoprotein subclass; metabolomics; metabonomics; nuclear magnetic resonance spectroscopy; quantification; risk assessment
This review focuses on (i) the current status of H-1 NMR spectroscopy to quantify lipoprotein subclasses directly from serum or plasma, and (ii) the applications of H-1 NMR metabonomics of serum in biomedicine. Related to both themes, experimental and data analysis methodologies are discussed together with the biochemical rationales. Particular emphasis is placed on the concepts of risk assessment and diagnostics in relation to the potential clinical role of H-1 NMR metabonomics; recent applications in the area of coronary heart disease and diabetes are addressed in more detail.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据